Anna Berg

Q: What is Anna Berg email address?

Email Anna Berg at anna.berg@astrazeneca.com. This email is the most updated Anna Berg email found in 2026.

Q: How to contact Anna Berg?

To contact Anna Berg send an email to anna.berg@astrazeneca.com. (updated on October 29, 2024)

Head of Operational Exellence & Quality Systems/Sr Q Dir at AstraZeneca | Greater Stockholm Metropolitan Area

About Anna Berg

Anna Berg is a seasoned professional in the pharmaceutical industry, currently serving as the Head of Operational Excellence & Quality Systems and Senior Quality Director at AstraZeneca. With a robust background in Quality Assurance, Anna has honed her expertise in critical areas such as Good Manufacturing Practices (GMP), validation processes, and regulatory compliance, making her a pivotal figure in ensuring the highest quality standards across all operations. Her role encompasses the comprehensive management of the Quality Management System (QMS) for external contract manufacturing, which includes drug products, drug substances, active pharmaceutical ingredients (APIs), excipients, and raw materials.

In her current position, Anna leads several key initiatives aimed at enhancing operational efficiency and quality assurance within AstraZeneca's external manufacturing landscape. She is at the forefront of implementing LEAN methodologies, optimizing portfolio management, and driving strategic improvements in business process management (BPM). Her leadership extends to overseeing import batch release processes, managing complaints, and ensuring the stability of products for external manufacturing. Additionally, Anna plays a crucial role in data and IT integration for external sourcing and logistics, ensuring that all systems align with regulatory requirements and industry best practices.

Anna's academic credentials, including a Master of Science in Biotechnology and a Postgraduate Diploma in Quality Management, complement her extensive experience. Her strong supply chain knowledge, combined with her skills in change control, corrective and preventive actions (CAPA), and computer system validation, positions her as a thought leader in the field. As she continues to navigate the complexities of the pharmaceutical landscape, Anna remains committed to fostering a culture of quality and operational excellence, driving AstraZeneca's mission to deliver safe and effective therapies to patients worldwide.

Anna Berg Work